We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
(+12%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
28.27%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$96.9M |
| 2 |
Merck
MRK
|
+$73.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$57.1M |
| 4 |
Illumina
ILMN
|
+$40.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$57.2M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$51.7M |
| 3 |
Kimberly-Clark
KMB
|
+$28.5M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$26.5M |
| 5 |
Arista Networks
ANET
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.77% |
| 2 | Technology | 20.35% |
| 3 | Consumer Discretionary | 9.49% |
| 4 | Communication Services | 7.69% |
| 5 | Financials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kodiak Sciences
KOD
$2.5B
| $21.7M | 0.2% |
366,348
-32,159
| -8% | -$1.61M |
|
127
3M
MMM
$91.8B
| $21.3M | 0.2% |
125,356
+41,446
| +49% | +$5.58M |
|
|
MYOK
128
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $21.3M | 0.2% |
155,972
+17,972
| +13% | +$1.91M |
|
129
Bank of America
BAC
$429B
| $21.1M | 0.2% |
877,440
+34,172
| +4% | +$851K |
|
130
Advanced Micro Devices
AMD
$700B
| $21M | 0.2% |
256,411
-46,311
| -15% | -$3.44M |
|
|
TPTX
131
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $20.5M | 0.19% |
235,163
-2,918
| -1% | -$203K |
|
132
Morgan Stanley
MS
$319B
| $20.4M | 0.19% |
421,777
+66,497
| +19% | +$3.35M |
|
133
Sociedad Química y Minera de Chile
SQM
$19.3B
| $20.2M | 0.19% |
622,000
-48,400
| -7% | -$1.51M |
|
134
Intuit
INTU
$91.1B
| $20M | 0.19% |
61,230
+1,362
| +2% | +$426K |
|
135
Synopsys
SNPS
$71.6B
| $19.6M | 0.18% |
91,612
+2,052
| +2% | +$418K |
|
136
Heron Therapeutics
HRTX
$93.4M
| $19.5M | 0.18% |
1,318,972
+40,000
| +3% | +$624K |
|
137
Southern Copper
SCCO
$138B
| $19.3M | 0.18% |
459,100
-94,927
| -17% | -$3.94M |
|
138
Zebra Technologies
ZBRA
$13.5B
| $19.2M | 0.18% |
76,082
+33,743
| +80% | +$9.08M |
|
139
Comcast
CMCSA
$87.3B
| $19M | 0.18% |
410,245
+20,408
| +5% | +$887K |
|
140
NetEase
NTES
$83B
| $19M | 0.18% |
208,700
-24,200
| -10% | -$2.28M |
|
|
CTXS
141
DELISTED
Citrix Systems Inc
CTXS
| $18.7M | 0.18% |
135,925
+35,414
| +35% | +$5.06M |
|
142
Automatic Data Processing
ADP
$109B
| $18.5M | 0.17% |
132,631
-52,984
| -29% | -$7.42M |
|
|
HUD
143
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $18.3M | 0.17% |
+2,406,686
| New | +$14.6M |
|
144
Masco
MAS
$14.6B
| $18.1M | 0.17% |
327,576
-26,533
| -7% | -$1.49M |
|
145
General Mills
GIS
$20.2B
| $17.9M | 0.17% |
289,712
+108,577
| +60% | +$6.79M |
|
|
BLUE
146
DELISTED
bluebird bio
BLUE
| $17.8M | 0.17% |
25,449
-6,770
| -21% | -$5.28M |
|
147
Advanced Drainage Systems
WMS
$10.6B
| $17.6M | 0.17% |
282,349
+35,334
| +14% | +$1.91M |
|
|
GRUB
148
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $17.6M | 0.17% |
+121,466
| New | +$17.5M |
|
149
Amphenol
APH
$185B
| $17.6M | 0.16% |
648,652
+252,488
| +64% | +$6.65M |
|
150
Ambarella
AMBA
$3.04B
| $17.2M | 0.16% |
329,085
+81,472
| +33% | +$3.94M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2020 Portfolio in Review
As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.
- Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
- Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
- Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
- Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
- Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
- Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
- Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.
Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.